The International Consortium of Lithium Genetics (ConLiGen): Achievements and Collaborations
https://doi.org/10.31363/2313-7053-2019-4-1-51-52
Abstract
Lithium is an indispensable tool of modern psychiatry. Although it is well-known that response to lithium is a familial trait, available research on pharmacogenetics regarding lithium treatment has, in the past, produced few reproducible results. The Consortium of Lithium Genetics (ConLiGen) was initiated by Thomas G. Schulze and Francis J. McMahon in 2008 to overcome these limitations. To date, researchers from 39 countries have joined the consortium, making it a truly international effort. A hallmark of the consortium is the use of an 11-point lithium response rating scale defined by Martin Alda and colleagues. The pooling of genotype data from over 2,500 patients phenotyped with this standardized response scale, have led to initial successes, which form the basis for further research.
About the Author
U. Heilbronner
Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich
Germany
Urs Heilbronner — PhD, Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich
Germany
Urs Heilbronner — PhD, Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich
References
1. Amare A.T., Schubert K.O., Hou L., Clark S.R., Papiol S., Heilbronner U., … Baune B.T. Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study. JAMA Psychiatryю 2018;75(1):65–74. https://doi.org/10.1001/jamapsychiatry.2017.3433
2. Garnham J., Munro A., Slaney C., Macdougall M., Passmore M., Duffy A., Alda M. Prophylactic treatment response in bipolar disorder: Results of a naturalistic observation study. Journal of Affective Disorders. 2007;104(1–3):185–190. https://doi. org/10.1016/j.jad.2007.03.003
3. Grof P., Duffy A., Cavazzoni P., Grof E., Garnham J., MacDougal, M., … Alda M. Is response to prophylactic lithium a familial trait? The Journal of Clinical Psychiatry. 2002;63(10):942–947. https:// doi.org/10.4088/jcp.v63n1013
4. Hou L., Bergen S.E., Akula N., Song J., Hultman C.M., Landén M., … McMahon F.J. Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder. Human Molecular Genetics. 2016;25(15):3383–3394. https://doi.org/10.1093/hmg/ddw181
5. Hou L., Heilbronner U., Degenhardt F., Adli M., Akiyama K., Akula N., … Schulze T.G. Genetic variants associated with response to lithium treatment in bipolar disorder: A genome-wide association study. The Lancet. 2016;387(10023):1085–1093. https://doi.org/10.1016/S0140-6736(16)00143-4
6. Kalman J.L., Papiol S., Forstner A.J., Heilbronner U., Degenhardt F., Strohmaier J., Schulze T. G. Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study. Bipolar Disorders. 2019;21(1):68–75. https://doi.org/10.1111/ bdi.12659
7. Manchia M., Adli M., Akula N., Ardau R., Aubry J.-M., Backlund L., Alda M. Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report. PLoS ONE. 2013;8(6):e65636. https://doi.org/10.1371/journal.pone.0065636
8. Papiol S., Schulze T.G., Alda M. Genetics of Lithium Response in Bipolar Disorder. Pharmacopsychiatry. 2018;51(5):206–211. https://doi. org/10.1055/a-0590-4992
9. Pisanu C., Heilbronner U., Squassina A. The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine. Mol Diagn Ther. 2018;22(4):409–420. https://doi.org/10.1007/ s40291-018-0335-y
10. Reinbold C. S., Forstner A. J., Hecker J., Fullerton J. M., Hoffmann P., Hou L., Cichon S. Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder. Front Psychiatry. 2018;9:207. https://doi.org/10.3389/fpsyt.2018.00207
11. Schulze T.G., Alda M., Adli M., Akula N., Ardau R., Bui E.T., McMahon F.J. The International Consortium on Lithium Genetics (ConLiGen): An initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology. 2010;62(1):72–78. https://doi. org/10.1159/000314708
12. Scott J., Etain B., Manchia M., Brichant-Petitjean C., Geoffroy P., Schulze T., ConLiGen collaborators. An examination of the quality and performance of the Alda scale for classifying lithium response phenotypes. Bipolar Disorders. 2019; https:// doi.org/10.1111/bdi.12829
Review
For citations:
Heilbronner U. The International Consortium of Lithium Genetics (ConLiGen): Achievements and Collaborations. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 2019;(4-1):51-52. https://doi.org/10.31363/2313-7053-2019-4-1-51-52
Views:
551
Email this article 